In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Ifeyinwa (Ify) Osunkwo of The Levine Cancer Institute/Atrium Health. They discuss unique issues facing the sickle cell disease population during the COVID-19 public health crisis as well as some benefits of using telemedicine and telementoring.
Related story
Original published date
Original source URL
Original source title
oneSCDvoice
Original updated date